###begin article-title 0
###xml 26 28 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 77 81 <span type="species:ncbi:10090">Mice</span>
Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: SD DH LM. Performed the experiments: SD JBG JC. Analyzed the data: SD JBG JC JML LM. Contributed reagents/materials/analysis tools: AB SMB AB KB DH. Wrote the paper: SD JML LM.
###end p 1
###begin p 2
###xml 436 438 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 543 545 543 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and serotonin transporters to produce efflux of dopamine and serotonin, respectively, in regions of the brain that have been implicated in reward. However, the role of serotonin/dopamine interactions in the behavioral effects of MDMA remains unclear. We previously showed that MDMA-induced locomotion, serotonin and dopamine release are 5-HT2B receptor-dependent. The aim of the present study was to determine the contribution of serotonin and 5-HT2B receptors to the reinforcing properties of MDMA.
###end p 2
###begin p 3
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 300 302 300 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 525 527 525 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 631 633 631 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
We show here that 5-HT2B-/- mice do not exhibit behavioral sensitization or conditioned place preference following MDMA (10 mg/kg) injections. In addition, MDMA-induced reinstatement of conditioned place preference after extinction and locomotor sensitization development are each abolished by a 5-HT2B receptor antagonist (RS127445) in wild type mice. Accordingly, MDMA-induced dopamine D1 receptor-dependent phosphorylation of extracellular regulated kinase in nucleus accumbens is abolished in mice lacking functional 5-HT2B receptors. Nevertheless, high doses (30 mg/kg) of MDMA induce dopamine-dependent but serotonin and 5-HT2B receptor-independent behavioral effects.
###end p 3
###begin p 4
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
These results underpin the importance of 5-HT2B receptors in the reinforcing properties of MDMA and illustrate the importance of dose-dependent effects of MDMA on serotonin/dopamine interactions.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Nestler1">[1]</xref>
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Nestler1">[1]</xref>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Alex1">[2]</xref>
###xml 664 667 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Alex1">[2]</xref>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-DeDeurwaerdere1">[3]</xref>
###xml 812 815 812 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bankson1">[4]</xref>
###xml 848 851 848 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bankson2">[5]</xref>
###xml 852 855 852 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Ball1">[8]</xref>
Activation of the mesolimbic dopaminergic system, which consists of projections from the midbrain ventral tegmental area (VTA) to forebrain regions, including the nucleus accumbens (NAcc), is critical for the psychostimulant and reinforcing effects of drugs of abuse [1]. Dopamine (DA) increase in the NAcc plays a critical role in reward and drug dependence and is a common response generated by all drugs of abuse [1]. On the other hand, emerging data support a role of serotonin (5-HT) in the rewarding effects of psychostimulants [2]. Serotonergic neurons from the dorsal raphe nucleus project to the VTA and the NAcc and impact dopaminergic neurotransmission [2], [3]. Thus, regulation of mesolimbic DA activity by 5-HT and its receptors plays an important role in the reinforcing effects of drugs of abuse [4], including the 'club drug' MDMA [5]-[8].
###end p 6
###begin p 7
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Rudnick1">[9]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Gudelsky1">[10]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Nash1">[12]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Liechti1">[13]</xref>
###xml 314 320 <span type="species:ncbi:9606">humans</span>
MDMA binds to and reverses the dopamine transporter (DAT) and the serotonin transporter (SERT) to produce carrier-mediated efflux of DA and 5-HT, respectively [9]. However, when access to SERT is blocked by selective serotonin reuptake inhibitors (SSRI), MDMA-evoked DA efflux in the NAcc is reduced [10]-[12]. In humans, relevant studies have shown that most of MDMA's effects are also markedly reduced after administration of 5-HT receptor antagonists or SSRIs, suggesting that these effects depend on SERT-mediated enhancement of 5-HT transmission [13]. In other words, MDMA-induced DA release in the NAcc is only partially carrier (DAT) - mediated but also involves a SERT-dependent 5-HT release.
###end p 7
###begin p 8
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bonaventure1">[14]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Duxon1">[17]</xref>
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Launay1">[18]</xref>
###xml 287 289 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Launay1">[18]</xref>
###xml 500 502 500 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bonaventure1">[14]</xref>
###xml 714 716 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 873 875 873 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 944 951 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 956 964 956 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 1099 1101 1099 1101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 533 538 <span type="species:ncbi:10090">mouse</span>
###xml 585 589 <span type="species:ncbi:10116">rats</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
Despite a widespread distribution in the central nervous system (CNS) [14]-[17], 5-HT2B receptor function in the brain is mainly unknown. However, 5-HT2B receptor mRNA and protein are coexpressed in SERT-expressing primary neurons from mice raphe nuclei [18]. This study showed that 5-HT2B receptors govern the overall 5-HT transport system by promoting phosphorylation of SERT in these neurons [18]. Using reverse transcription polymerase chain reaction (RT-PCR), we recently confirmed that the 5-HT2B receptor mRNA is expressed in mouse raphe nucleus [19], as previously observed in rats by DNA microarray and in situ hybridization [14]. Moreover, acute pharmacological inhibition or genetic ablation of the 5-HT2B receptor in mice completely abolishes MDMA (10 mg/kg)-induced hyperlocomotion and 5-HT/DA release in NAcc and VTA [19]. Indeed, functional pre-synaptic 5-HT2B receptors are required for MDMA-induced SERT dependent 5-HT release in vivo and in vitro[19]. The absence of 5-HT and DA release in the NAcc raises the question of the MDMA reinforcing effect in mice lacking functional 5-HT2B receptors.
###end p 8
###begin p 9
###xml 67 69 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 238 240 238 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 269 271 269 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 415 417 415 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 417 420 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 614 616 614 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 616 619 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 677 679 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1076 1078 1076 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1078 1081 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1147 1151 1147 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
###xml 1157 1172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
The main goal of the present study was to evaluate the role of 5-HT2B receptors in activation of mesolimbic dopaminergic system and the reinforcing effects of MDMA. We first compared the behavioral effect of MDMA (10 and 30 mg/kg) in 5-HT2B-/-, RS127445 (selective 5-HT2B receptor antagonist)-treated and WT (wild type) mice using locomotor sensitization. NAcc microdialysis studies were performed in awake WT, 5-HT2B-/- and RS127445-treated WT mice to evaluate the effects of acute MDMA (30 mg/kg) injection on DA and 5-HT extracellular levels. We then performed conditioned place preference paradigms in WT, 5-HT2B-/- and RS127445-treated WT mice to evaluate the role of 5-HT2B receptor in the reinforcing effects effect of MDMA. Psychostimulants and other drugs of abuse, including MDMA, activate extracellular signal-regulated kinase (ERK) in the striatum, an essential component of a signaling pathway involved in synaptic plasticity and long-term effects of drugs of abuse. Thus, we quantified phosphorylated-ERK (p-ERK) immunoreactive neurons in the NAcc of WT and 5-HT2B-/- mice after MDMA conditioning in the CPP paradigm. Finally, using drd2-EGFP transgenic mice, we characterized-for the first time- the populations of striatal dopaminergic neurons in which MDMA activates the pERK signaling pathways in mice expressing CPP.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
Animals
###end title 11
###begin p 12
###xml 4 6 4 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Gong1">[20]</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
5-HT2B-/- mice used in these experiments were made in a pure 129Sv/PAS background. Wild type 129/SvPAS mice (8-10 week old) used as a control group were bred in-house. Swiss-Webster male mice (10 week-old) carrying drd2-EGFP bacterial artificial chromosome transgenes were generated by the Gene Expression Nervous System Atlas program at Rockefeller University (New York) [20]. Groups were composed of 50% male and 50% female for each experiment.
###end p 12
###begin title 13
Ethics Statement
###end title 13
###begin p 14
###xml 133 143 127 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
Mice were kept under controlled environmental conditions (22degreesC, 12 h alternate light-dark cycles, 50% humidity, food and water ad libitum). The surgical procedures were performed under deep anesthesia (pentobarbital 25 microg/g, xylazine 20 microg/g). Behavioral tests and animal care were conducted in accordance with the standard ethical guidelines (National Institutes of Health's "Guide for the care and use of Laboratory animals", and the European Communities Council European Communities Directive 86/609 EEC). All experiments involving mice were approved by the Ile de France Regional Ethics Committee for Animal Experiments.
###end p 14
###begin title 15
Microdialysis
###end title 15
###begin p 16
###xml 2213 2214 2205 2206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2216 2217 2208 2209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2228 2229 2220 2221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">Mice</span>
###xml 1218 1222 <span type="species:ncbi:10090">Mice</span>
Anesthetized animals were placed in a stereotaxic frame (D. Kopf, Tujunga, CA, USA) and a stainless-steel guide cannula (CMA/12, CMA Microdialysis, North Chelmsford, MA, USA; outer diameter 0.7 mm) was implanted in the NAcc. The cannula was then secured to the skull with dental cement, and the skin was sutured. Animals were kept in individual cages for a seven-day recovery. The microdialysis experiment was performed using awake mice. Dialysis probes were equipped with a Cuprophan membrane (membrane length 1 mm and diameter 0.24 mm, cutoff: 5,000 Da, Microdialysis AB, Sweden). According to Franklin and Praxinos (1997), stereotaxic coordinates in mm were for NAcc AP +1.2, ML +0.6, DV -4.2 both to bregma and dura surface, respectively. Probes were perfused at a constant rate of 5 microl/min with artificial CSF containing 154.1 mM Cl-, 147 mM Na+, 2.7 mM K+, 1 mM Mg2+, and 1.2 mM Ca2+, adjusted to pH 7.4 with 2 mM sodium phosphate buffer in awake animals. Dialysates were collected every 10 min. All measurements were carried out 150 min after the beginning of perfusion, by which time a steady state was achieved. Mice were injected with MDMA (30 mg/kg; i.p) 35 minutes after the beginning of measurements. Mice received a saline or RS127445 (0.5 mg/kg; i.p) injection 30 min before the MDMA injection. At the end of the experiment, all brains were fixed in a 4% formaldehyde solution and serial coronal slices were made on a microtome. Histological examination of cannula tip placement was subsequently made on 100 microm safranine-stained coronal sections. Dialysate samples were injected without any purification into an HPLC system that consists of a pump linked to an automatic injector (Agilent 1100, Palo Alto, CA, USA), a reverse-phase column (Zorbax SB C18, 3.5 lm, 150 . 4.6 mm; Agilent Technologies, Palo Alto, CA, USA) and a coulometric detector (Coulochem II; ESA Inc., Chelmsford, USA) with a 5011 analytical cell to quantify DA or 5-HT. The first electrode was fixed at -100 mV and the second electrode at +300 mV. The gain of the detector was set at 50 nA. The signal of the second electrode was connected to an HP Chemstation for HPLC. The composition of the mobile phase was 50 mM NaH2PO4, 0.1 mM Na2EDTA, 0.65 mM octyl sodium sulphate and 14% (v/v) methanol, pH 3.5. The flow rate was set at 1 ml/min.
###end p 16
###begin title 17
Locomotor Activity
###end title 17
###begin p 18
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">Mice</span>
Locomotor activity was measured in a circular corridor with four infrared beams placed at every 90degrees (Imetronic, France). Counts were incremented by consecutive interruption of two adjacent beams (i.e., mice moving through one-quarter of the corridor). Mice were injected with a saline solution and individually placed in the activity box for 30 min during 3 days consecutively for habituation before all locomotor experiments.
###end p 18
###begin title 19
Locomotor Sensitization
###end title 19
###begin p 20
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Valjent1">[21]</xref>
###xml 132 138 132 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Fig. 1</xref>
###xml 436 438 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 141 145 <span type="species:ncbi:10090">Mice</span>
###xml 261 265 <span type="species:ncbi:10090">Mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">Mice</span>
We used two models of locomotor sensitization in this study, a two-injection protocol [21] and a repeated drug injections protocol (Fig. 1). Mice received a first injection of MDMA and the locomotor activity was recorded for two hours (two-injection protocol). Mice were then challenged seven days later with a second injection of MDMA (test injection) and the locomotor activity was recorded for two hours. For testing the role of 5-HT2B receptors in the induction of sensitization, mice received a saline or RS127445 (0.5 mg/kg) injection 30 min before the first MDMA injection. For the repeated drug injections protocol, mice received a daily injection of MDMA (10 mg/kg) during 5 days and the locomotor activity was recorded during two hours. Mice were then challenged 5 days later with a single injection (MDMA 10 mg/kg) and locomotor activity was recorded during two hours.
###end p 20
###begin title 21
Effect of 5-HT2B receptor inhibition on locomotor activity and behavioral sensitization after MDMA injection.
###end title 21
###begin p 22
###xml 72 74 72 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Locomotor sensitization after MDMA two-injection protocol in WT and 5-HT<sub>2B</sub><sup>&#8722;/&#8722;</sup> mice (A&#8211;D):</bold>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 198 200 198 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 209 210 209 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 424 426 424 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 436 435 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 470 471 470 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 502 504 502 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 749 750 749 750 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 841 843 841 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 881 882 881 882 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1023 1025 1023 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1025 1028 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1034 1035 1034 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1057 1058 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1123 1126 1121 1124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;D</bold>
###xml 1155 1158 1153 1156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B&#8211;C</bold>
###xml 1272 1273 1270 1271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1275 1276 1273 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1292 1293 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1304 1305 1302 1303 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1307 1308 1305 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1324 1325 1322 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1369 1370 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1397 1398 1395 1396 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1426 1427 1424 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1453 1454 1451 1452 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1478 1479 1476 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1504 1505 1502 1503 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1512 1513 1510 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1539 1540 1537 1538 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1620 1621 1618 1619 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1623 1624 1621 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1700 1702 1698 1700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 1719 1720 1717 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1768 1769 1766 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1842 1843 1840 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1893 1894 1891 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1963 1964 1961 1962 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2008 2009 2006 2007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2026 2027 2024 2025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2281 2283 2255 2257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 2363 2365 2337 2339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2365 2368 2339 2342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2295 2378 2269 2352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Locomotor sensitization after repeated MDMA injection in WT and 5-HT<sub>2B</sub><sup>&#8722;/&#8722;</sup> mice (E):</bold>
###xml 2493 2495 2467 2469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2495 2498 2469 2472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2837 2839 2811 2813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2839 2842 2813 2816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2868 2869 2840 2841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 84 87 <span type="species:ncbi:10090">A-D</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1123 1126 <span type="species:ncbi:10090">A-D</span>
###xml 2213 2217 <span type="species:ncbi:10090">mice</span>
###xml 2369 2373 <span type="species:ncbi:10090">mice</span>
###xml 2473 2477 <span type="species:ncbi:10090">mice</span>
###xml 2499 2503 <span type="species:ncbi:10090">mice</span>
###xml 2643 2647 <span type="species:ncbi:10090">mice</span>
###xml 2801 2805 <span type="species:ncbi:10090">mice</span>
###xml 2843 2847 <span type="species:ncbi:10090">mice</span>
###xml 3121 3125 <span type="species:ncbi:10090">mice</span>
Locomotor sensitization after MDMA two-injection protocol in WT and 5-HT2B-/- mice (A-D): MDMA (10 mg/kg i.p.) increases locomotor activity after the first injection (1st) in WT mice but not in 5-HT2B-/- mice A) or RS127445-treated WT mice B). The stimulant effect of a challenge dose of MDMA (10 mg/kg) 7 days later (2nd) was significantly enhanced compared to the first injection in WT mice, while it had no effect in 5-HT2B-/- mice A) or RS127445 pre-treated WT mice B). To evaluate the role of 5-HT2B receptors in the development of locomotor sensitization, WT mice were treated with RS127445 30 min before the first injection of MDMA. The increased responsiveness to the challenge injection of MDMA in absence of RS127445 was totally abolished C). MDMA (30 mg/kg i.p.) induces locomotor activity after the first injection in WT and 5-HT2B-/- mice compared to saline injection D). The stimulant effect of a challenge dose of MDMA (30 mg/kg) was significantly enhanced compared to the first injection in both WT and 5-HT2B-/- mice D). Data (means+/-SEM, n = 8-14 per group) were analyzed by two-way ANOVA with genotype (A-D) or RS127445 pre-treatment (B-C) and MDMA treatment as main factors. A significant interaction was observed for the locomotor activity in figure A) F (2,66) = 12.86 p<0.01, and B) F (2,54) = 11.49 p<0.01, as well as a main effect of genotype F (2, 66) = 15.68, p<0.001 (A) or RS127445 pre-treatment F (2, 54) = 10.24, p<0.05 (B) and of MDMA treatment F (1,66) = 9.26, p<0.001 (A), and F (1,54) = 17.04, p<0.001 (B). No significant interaction was observed for the locomotor activity in figure C) F (2,66) = 3.57, ns, whereas a main effect of RS127445 pre-treatment at the 1st MDMA injection, F (2,66) = 28.56, p<0.001, and of MDMA treatment F (1,66) = 6.64, p<0.01 were detected. Neither a significant interaction, F (2,50) = 0.25, ns, nor a main effect of genotype F (1,50) = 0.9, ns, was observed for the locomotor activity in figure D), whereas a main effect of MDMA treatment, F (2,50) = 82.72, p<0.001, was detected. Bonferroni tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; *p<0.05; **p<0.01; ***p<0.001 compared to saline-treated mice. degreesp<0.05; degreesdegreesdegreesp<0.001 compared to MDMA 1st injection. Locomotor sensitization after repeated MDMA injection in WT and 5-HT2B-/- mice (E): MDMA (10 mg/kg i.p.) increases locomotor activity after the first injection (day 1; d1) in WT mice but not in 5-HT2B-/- mice compare to saline injection. Repeated MDMA injection during the following days (Day 2 to 5, d2-d5) increases locomotor activity only in WT mice. The stimulant effect of a challenge dose of MDMA (10 mg/kg) 5 days later (day 10; d10) was significantly enhanced compared to the first injection in WT mice, while it had no effect in 5-HT2B-/- mice. Data (means+/-SEM, n = 8 per group) were analyzed by two-way ANOVA with genotype and MDMA treatment as main factors. Bonferroni tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; **p<0.01; ***p<0.001 compared to saline-treated mice. degreesdegreesdegreesp<0.001 compared to MDMA day 1 injection.
###end p 22
###begin title 23
CPP Acquisition
###end title 23
###begin p 24
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Tzschentke1">[22]</xref>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">Mice</span>
###xml 1316 1320 <span type="species:ncbi:10090">mice</span>
CPP experiment, consisting of three phases, was carried out following a procedure biased in terms of initial spontaneous preference [22]. CPP was assessed in a two-compartment apparatus (Imetronic, Pessac, France) with different patterns on floors and walls, separated by a central neutral area. During the first phase or pre-conditioning (Pre-C) mice were given access to both compartments of the apparatus for 30 min each day for four days. On day four, the time spent by the animal in each compartment was recorded for 30 min. In the second phase (conditioning), animals were conditioned with MDMA or saline through four pairings with the non-preferred or preferred compartment respectively. Mice received only one pairing each day. Animals conditioned with MDMA received an injection of MDMA 10 min before confinement in the drug-paired compartment for 30 min on days 5, 7, 9, and 11 and received physiological saline 10 min before being confined to the vehicle-paired compartment for 30 min on days 6, 8, 10, and 12; control animals received an injection of physiological saline 10 min before being confined for 30 min to each compartment alternatively. During the third phase or post-conditioning (Post-C), on day 13, the guillotine doors separating the two compartments were removed and the time spent by the mice (untreated) in each compartment was recorded during 30 min. The difference in seconds between the time spent in the drug-paired compartment in the Post-C test and that spent in the Pre-C test is a measure of the degree of conditioning induced by the drug (Score). If this difference is positive then the drug has induced a preference for the drug-paired compartment, whereas the opposite indicates the induction of an aversion.
###end p 24
###begin title 25
Extinction
###end title 25
###begin p 26
Control and MDMA-conditioned groups underwent an extinction session during which the animals were placed in the apparatus (without guillotine doors separating the compartments) for 30 min until the time spent in the drug-paired compartment for each group conditioned with MDMA was similar to those of Pre-C (one extinction session per day during 12 days). MDMA-treated animals received the same number of extinction sessions, independently of their individual scores, as the criterion of extinction was a lack of significant difference with respect to Pre-C values. Saline conditioned groups only performed one extinction session to confirm the lack of CPP.
###end p 26
###begin title 27
Reinstatement
###end title 27
###begin p 28
###xml 279 281 279 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
The effects of a priming dose of MDMA were evaluated 48 h after the confirmation of extinction. The tests of reinstatement were the same as for Post-C (free ambulation for 30 min) except that animals were tested 24 h after the administration of MDMA. For testing the role of 5-HT2B receptors in the induction of reinstatement, mice received saline or RS127445 (0.5 mg/kg) 30 min before the MDMA priming injection.
###end p 28
###begin title 29
Tissue Preparation and Immunofluorescence
###end title 29
###begin p 30
###xml 49 51 49 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 825 829 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-BertranGonzalez1">[23]</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
Twenty-four hours after CPP training, WT and 5-HT2B-/- mice were re-exposed to saline, MDMA 10 mg/kg or MDMA 30 mg/kg. Ten minutes after re-exposure, mice were rapidly anesthetized with pentobarbital (30 mg/kg, i.p.; Sanofi-Aventis) and perfused transcardially with 4% (w/v) paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.5. Brains were postfixed overnight in the same solution and stored at 4degreesC. Thirty-micrometer-thick sections were cut with a Vibratome (Leica) and stored at -20degreesC in a solution containing 30% (v/v) ethylene glycol, 30% (v/v) glycerol, and 0.1 M sodium phosphate buffer, until they were processed for immunofluorescence. Brain regions were identified using a mouse brain atlas and sections equivalent to 1.54 mm from Bregma were taken. Sections were processed as previously described [23].
###end p 30
###begin title 31
Immunofluorescence Analysis
###end title 31
###begin p 32
###xml 555 559 <span type="species:ncbi:10090">mice</span>
Confocal microscopy and image analysis were performed at the Institut du Fer a Moulin Imaging Facility. Double- and triple-labeled images from each region of interest were obtained bilaterally using sequential laser-scanning confocal microscopy (SP2; Leica). Neuronal quantification was performed in 375x375 microm images by counting nuclear EGFP fluorescence (for assessment of D2R-positive cells) and nuclear/cytoplasm Cy3 immunofluorescence (for each marker analyzed). Cell counts were performed by an observer unaware of the treatment received by the mice.
###end p 32
###begin title 33
Reagents
###end title 33
###begin p 34
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bonhaus1">[24]</xref>
###xml 338 340 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 489 493 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bonhaus1">[24]</xref>
###xml 564 566 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 858 862 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
MDMA (Sigma-Aldrich, Saint-Quentin Fallavier, France) and 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (RS127445) [24] (Tocris Bioscience, USA) were slowly dissolved in 0.9% (wt/vol) NaCl solution (saline). All drugs were administered i.p (0.1 ml/10 g body weight). RS-127445 was found to have sub-nanomolar affinity for the 5-HT2B receptor (pKi = 9.5+/-0.1) and at least 1,000 fold selectivity for this receptor as compared to numerous other receptors and monoamine uptake sites [24]. The acute pharmacological inhibition and genetic deletion of the 5-HT2B receptor gives rise to an identical phenotype vis-a-vis MDMA-induced behavioral effect. Based on the initial study showing that RS127445 completely (1; 0.5 and 0.1 mg/kg; i.p) or partially (0.05 mg/kg) blocked MDMA-induced locomotion in WT mice and had no effect on basal locomotor activity [19] we used the 0.5 mg/kg dose (i.p).
###end p 34
###begin title 35
Statistics
###end title 35
###begin p 36
Microdialysis data were analyzed by two-way ANOVA repeated measures with drug treatment and time as factors. Behavioral and biochemical assays were analyzed by two-way analysis of variance (ANOVA) with treatment and genotype as main factors. Bonferroni or Dunnett test were used for post hoc comparisons depending on the experiment. P<0.05 was predetermined as the threshold for statistical significance.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
Effect of 5-HT2B Receptor Inhibition on Behavioral Sensitization to Repeated MDMA Injection
###end title 38
###begin p 39
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Stewart1">[25]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Berridge1">[26]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Robinson1">[27]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Vezina1">[28]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Crespi1">[29]</xref>
###xml 668 670 668 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 709 717 709 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1</xref>
###xml 720 729 720 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1A</xref>
###xml 759 761 759 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 941 943 941 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1104 1106 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1106 1109 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1116 1125 1116 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1A</xref>
###xml 1153 1162 1153 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1B</xref>
###xml 1358 1360 1358 1360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1360 1363 1360 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1385 1392 1385 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Fig. 1E</xref>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1379 1383 <span type="species:ncbi:10090">mice</span>
Behavioral sensitization corresponds to a progressive enhancement of locomotor responses following repeated exposure to drug abuse [25]. Once established, sensitization is long-lasting since it is observed after re-exposure to the drug several weeks later [26], [27]. Locomotor sensitization is thought to underlie important aspects of vulnerability to drug addiction [28]. Since MDMA binds to DAT with a lower affinity than SERT [29] it may differentially affect these transporters, at low (10 mg/kg) or high (30 mg/kg) doses. We thus measured locomotor activity and behavioral sensitization in response to low (10 mg/kg) and high doses (30 mg/kg) of MDMA in WT, 5-HT2B-/- or RS127445-treated wildtype mice (Figure 1). Figure 1A shows that acute injection (1st injection) of MDMA (10 mg/kg) increases locomotor activity compared to saline injection in WT mice. The stimulant effect of a challenge dose of MDMA (10 mg/kg) seven days later (2nd injection) was significantly enhanced compared to the first injection in WT mice. However, neither the first nor the second injection induced locomotion in 5-HT2B-/- mice (Figure 1A) or RS127445-treated mice (Figure 1B) compared to saline injection. In the same way, locomotor sensitization induced with a repeated injection paradigm (i.e. daily injection of MDMA 10 mg/kg during 5 days) was also abolished in 5-HT2B-/- compared to WT mice (Fig. 1E).
###end p 39
###begin p 40
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 125 127 125 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 346 348 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 416 418 416 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 463 472 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1C</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
To evaluate the role of 5-HT2B receptors in the locomotor sensitization induction, WT mice were treated with a selective 5-HT2B receptor antagonist (RS127445; 0.5 mg/kg) 30 min before the first injection of MDMA. The challenge injection of MDMA was then performed in absence of RS127445; the increased responsiveness to the challenge injection (2nd) of MDMA was thus totally abolished, supporting a role for the 5-HT2B receptor in the induction of sensitization (Figure 1C).
###end p 40
###begin p 41
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 171 180 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g001">Figure 1D</xref>
###xml 266 268 266 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
By contrast, in both WT and 5-HT2B-/- mice, a high dose of MDMA (30 mg/kg) induced a 30-fold increase in locomotion and a significant increase in locomotor sensitization (Figure 1D). These experiments indicate that, unlike low doses, high doses of MDMA induce a 5-HT2B receptor-independent sensitization in mice.
###end p 41
###begin title 42
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Effect of 5-HT2B Receptor Inhibition on MDMA (30 mg/kg)-Evoked Increase in 5-HT and DA Level in NAcc as Measured by In Vivo Microdialysis
###end title 42
###begin p 43
###xml 110 112 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 362 364 362 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2A</xref>
###xml 587 589 587 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 599 615 599 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2A and 2C</xref>
###xml 766 775 766 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2B</xref>
###xml 785 787 785 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 903 932 903 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2B and 2D respectively</xref>
###xml 989 1005 989 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2E and 2F</xref>
###xml 1034 1036 1034 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1036 1039 1036 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1108 1110 1108 1110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1261 1263 1261 1263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1350 1352 1350 1352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1352 1355 1352 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1356 1360 <span type="species:ncbi:10090">mice</span>
We have previously shown that MDMA (10 mg/kg)-induced hyperlocomotion, 5-HT and DA release are abolish in 5-HT2B-/- or RS127445 treated mice [19]. In order to understand the contrasting behavioral results observed between low (10 mg/kg) and high (30 mg/kg) doses of MDMA, we compared changes in accumbal 5-HT and DA extracellular concentrations in awake WT, 5-HT2B-/- and RS127445-treated mice (Figure 2). In WT mice, MDMA (30 mg/kg) induced a 160-fold increase in extracellular 5-HT levels in the NAcc within 80 minutes (Figure 2A), an effect that was absent in RS127445-treated or 5-HT2B-/- mice (Figure 2A and 2C respectively). However, MDMA (30 mg/kg) caused a 100-fold increase in extracellular DA concentration in the NAcc of wild type mice within 50 minutes (Figure 2B); in 5-HT2B-/- or RS127445-treated mice, MDMA elicited a 50-fold increase in synaptic DA levels in the NAcc within 30 minutes (Figure 2B and 2D respectively). Basal 5-HT and DA extracellular level are reported in Figure 2E and 2F respectively for WT and 5-HT2B-/- mice. Therefore, the dependence of MDMA-induced 5-HT release on 5-HT2B receptors persists even at a high dose (30 mg/kg) of MDMA; the remaining MDMA-induced DA release, however, appears to be partially independent of 5-HT2B receptors and may explain the hyperlocomotion and locomotor sensitization seen in 5-HT2B-/- mice that are not observed at 10 mg/kg of MDMA.
###end p 43
###begin title 44
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT2B receptor inhibition on MDMA (30 mg/kg) - evoked increase in NAcc 5-HT and DA levels as measured by in vivo microdialysis in awake mice.
###end title 44
###begin p 45
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 252 253 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 432 433 432 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 439 440 439 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 501 502 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 732 733 730 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 734 735 732 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 753 754 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 772 773 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 805 806 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 825 826 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 893 894 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 938 939 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1031 1032 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1078 1079 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1128 1129 1126 1127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1130 1131 1128 1129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1193 1194 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1250 1251 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1270 1271 1268 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1313 1314 1311 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1348 1349 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1445 1446 1443 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1493 1494 1491 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
Effect of MDMA (30 mg/kg i.p.) or saline injection on (A) 5-HT, (B) DA concentrations in dialysates from the NAcc of WT or RS127445 (0.5 mg/kg i.p.)-WT pre-treated mice. Effect of 5-HT2B receptor genetic ablation on MDMA (30 mg/kg)-induced changes in (C) 5-HT or (D) DA levels in NAcc. MDMA or saline solutions were injected 35 minutes after test began (arrow). Basal 5-HT and DA extracellular levels are reported at lower scale in E) and F) respectively for WT and 5-HT2B-/- mice. Data (means+/-SEM, n = 4-5 per group) were analyzed by two-way ANOVA (repeated measures) with RS-administration or genotype and time as main factors. A significant interaction was observed after 5-HT2B receptor pharmacological inhibition (RS127445) (A-B) for 5-HT levels F (36,180) = 429.5 p<0.001 as well as for DA levels F (36,180) = 82.43, p<0.001. A main effect of RS-treatment was observed for 5-HT levels F (2, 180) = 3677, p<0.001 and for DA levels F (2, 180) = 449.7, p<0.001, whereas a main effect of time was also detected for 5-HT levels F (18, 180) = 498.1, p<0.001 and for DA levels F (18, 180) = 166.5, p<0.001. For 5-HT2B-/- mice (C-D), a significant interaction was not observed for 5-HT levels F (18,126) = 1.33, ns, but it was the case for DA levels F (18,126) = 53.98, p<0.001. Neither a main effect of genotype F (1, 126) = 0.36, ns, nor of time F (18, 126) = 1.08, ns, was observed for 5-HT levels. On the contrary, a main effect of genotype F (1, 126) = 363.3, p<0.001, as well as of time F (18, 126) = 53.55, p<0.001 was detected for DA levels. Bonferroni tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; *p<0.001.
###end p 45
###begin title 46
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
Effect of 5-HT2B Receptor Inhibition on MDMA-Induced CPP and CPP Reinstatement
###end title 46
###begin p 47
###xml 37 39 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 109 111 109 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Tzschentke1">[22]</xref>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g003">Figure 3A</xref>
###xml 622 624 622 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 749 751 749 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 751 754 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 761 770 761 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g003">Figure 3A</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
In order to evaluate the role of 5-HT2B receptors in the reinforcing effects of MDMA, we compared WT and 5-HT2B-/- mice in the CPP paradigm. CPP is a robust model used to assess the addictive properties of drugs of abuse [22]. This procedure is based on the fact that the pairing of neutral distinctive environmental stimuli with a drug results in an acquired preference for those specific stimuli. As shown in Figure 3A, repeated injection of MDMA (10 mg/kg) in the paired compartment induces CPP in WT mice compared to saline-injected WT mice. In contrast, MDMA (10 mg/kg)-induced CPP in WT mice was not observed in 5-HT2B-/- mice. However, as observed for locomotor sensitization, a high dose of MDMA (30 mg/kg) did induce CPP in both WT and 5-HT2B-/- mice (Figure 3A).
###end p 47
###begin title 48
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT2B receptor inhibition on MDMA-induced conditioned place preference in mice.
###end title 48
###begin p 49
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 131 133 131 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 243 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 243 246 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 272 273 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 402 403 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 454 455 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 506 507 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 685 686 683 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 899 900 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
A) Repeated i.p. injection of MDMA 10 mg/kg induced CPP in WT mice compared to saline injection, but this effect was absent in 5-HT2B-/- mice. However, repeated injection of a high dose of MDMA (30 mg/kg) induced CPP in WT as well as in 5-HT2B-/- mice. Data (means+/-SEM, n = 8 per group) were analyzed by two-way ANOVA with genotype and treatment as main factors, revealing a significant interaction, F(2, 41) = 3.93, p<0.05, a main effect of treatment F(2, 41) = 11.67, p<0,001 but no effect of genotype F(1, 41) = 0.27, ns. Bonferroni tests were used for post-hoc comparisons. In all cases, p<0.05 was considered statistically significant; **p<0.01 compared to saline-treated mice. B) After an initial extinction of the CPP (12 days) in WT mice, MDMA (10 mg/kg) re-exposure induced reinstatement of CPP. MDMA-induced reinstatement was not observed in RS127445-pretreated mice. Data (means+/-SEM, n = 10-20 per group) were analyzed by one-way ANOVA. Dunnetts tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; *p<0.05 **p<0.01 compared to saline-treated mice.
###end p 49
###begin p 50
###xml 274 283 274 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Figure 2B</xref>
###xml 441 443 441 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 547 549 547 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 745 747 745 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 81 87 <span type="species:ncbi:9606">humans</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
Reinstatement of drug-seeking behavior in animals is relevant to drug relapse in humans. We employed the CPP paradigm to investigate the extinction and reinstatement of the place-conditioned response to MDMA injection, a model that is consistent with drug-seeking behavior. Figure 2B shows that MDMA (10 mg/kg) re-exposure induces reinstatement of CPP after an initial extinction of CPP (12 days) in WT mice. To evaluate the role of the 5-HT2B receptor in the reinstatement of CPP, mice expressing CPP extinction were treated with a selective 5-HT2B receptor antagonist (RS127445, 0.5 mg/kg ip) or saline solution 30 min before MDMA re-exposure. MDMA-induced reinstatement was completely blocked in RS127445-pretreated mice, indicating that 5-HT2B receptors are required for the induction of CPP reinstatement.
###end p 50
###begin title 51
Effect of 5-HT2B Receptor Inhibition on MDMA-Induced ERK Activation
###end title 51
###begin p 52
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Girault1">[30]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Salzmann1">[31]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 486 488 486 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 630 636 630 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">Fig. 2</xref>
###xml 682 688 682 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g003">Fig. 3</xref>
###xml 733 735 733 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 923 925 923 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 925 928 925 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1014 1023 1014 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g004">Figure 4A</xref>
###xml 1080 1082 1080 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1082 1085 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1159 1168 1159 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g004">Figure 4B</xref>
###xml 1336 1338 1336 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1338 1341 1338 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1675 1677 1675 1677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1677 1680 1677 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1733 1735 1733 1735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1735 1738 1735 1738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1745 1761 1745 1761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g004">Figure 4B and 4C</xref>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
###xml 1581 1585 <span type="species:ncbi:10090">mice</span>
###xml 1681 1685 <span type="species:ncbi:10090">mice</span>
###xml 1739 1743 <span type="species:ncbi:10090">mice</span>
Accumbal ERK stimulation participates in the long-lasting behavioral effects of drugs of abuse, [30] including CPP induced by MDMA [31]. This regulation required combined activation of dopamine and glutamate receptors. Thus, phosphorylation of ERK provides an index of post-synaptic DA receptor activation in the NAcc. The absence of DA release in the NAcc after acute MDMA (10 mg/kg) injection [19] and CPP after MDMA (10 mg/kg) conditioning indicates that mice lacking functional 5-HT2B receptor should not exhibit ERK activation with low dose of MDMA. By contrast, DA release in the NAcc after acute MDMA (30 mg/kg) injection (Fig. 2) and CPP after MDMA (30 mg/kg) conditioning (Fig. 3) indicates that mice lacking functional 5-HT2B receptor should exhibit ERK activation with high dose of MDMA. In order to assess this question, we quantified phosphorylated-ERK (p-ERK) immunoreactive neurons in the NAcc of WT and 5-HT2B-/- mice 24 hours after the last MDMA (10 or 30 mg/kg) conditioning in the CPP paradigm (Figure 4A). Basal ERK phosphorylation was determined in WT or 5-HT2B-/- mice that received saline injection during the CPP paradigm. As shown in Figure 4B, MDMA (10 mg/kg) re-exposure induced a 10-fold increase in p-ERK immuno-positive neurons in the NAcc (only in the shell) of WT mice expressing CPP. Conversely, in 5-HT2B-/- mice, which did not express CPP after MDMA (10 mg/kg) conditioning, no significant increase of p-ERK immuno-positive neurons in the NAcc was seen after MDMA injection. However, a high dose of MDMA (30 mg/kg) induced-as it did in wild type mice- a 12-fold increase in p-ERK immuno-positive neurons in the NAcc (shell and core) of 5-HT2B-/- mice expressing CPP compared to saline-injected 5-HT2B-/- mice (Figure 4B and 4C).
###end p 52
###begin title 53
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
Effect of 5-HT2B receptor on MDMA-induced ERK activation.
###end title 53
###begin p 54
###xml 29 37 29 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g003">Figure 3</xref>
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 272 274 272 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 330 334 326 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, C</bold>
###xml 405 406 401 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 423 424 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 440 442 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 442 445 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 604 606 600 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 606 609 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 852 853 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 896 897 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 975 976 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1019 1020 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1094 1095 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1132 1133 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 1310 1314 <span type="species:ncbi:10090">mice</span>
###xml 1381 1385 <span type="species:ncbi:10090">mice</span>
24 hours after CPP training (Figure 3), the same WT and 5-HT2B-/- mice were re-exposed to saline, MDMA 10 mg/kg or MDMA 30 mg/kg before being processed for immunohistochemistry. A) Single confocal sections showing p-ERK1/2 immunoreactivity in the NAcc Shell of WT and 5-HT2B-/-mice 10 min after re-exposure. Scale bar: 40 microm. B, C) Quantification of p-ERK1/2 immunoreactive neurons in the NAcc Shell (B) and NAcc Core (C) of WT and 5-HT2B-/- mice 10 min after re-exposure. Note the strength of ERK activation induced by re-exposure to both MDMA doses in WT animals. This activation was absent in 5-HT2B-/- mice at 10 mg/kg MDMA, although it fully recovered at 30 mg/kg MDMA. Data (means+/-SEM; n = 4-10 mice per group) were analyzed using two-way ANOVA with genotype and treatment as main factors, revealing a significant interaction in NAcc Shell F(2, 33) = 21.27, p<0,001 and in NAcc Core, F(2, 33) = 4.77, p<0.05. A main effect of treatment was observed in NAcc Shell F(2, 33) = 45.29, p<0,001 and in NAcc Core, F(2, 33) = 21.85, p<0,001, but no effect of genotype neither in NAcc Shell F(1, 33) = 0.53, ns nor in NAcc Core, F(1, 33) = 0.21, ns. Bonferroni tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; ** p<0.01, *** p<0.001 compared to saline-treated mice; degreesdegreesdegrees p<0.001, compared to MDMA 10 mg/kg treated mice.
###end p 54
###begin title 55
MDMA-Induced ERK Activation Occurs Only in D1R-Expressing NAcc Neurons
###end title 55
###begin p 56
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g005">Figure 5</xref>
###xml 520 536 520 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g005">Figure 5A and 5C</xref>
###xml 620 629 620 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g005">Figure 5B</xref>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
In order to characterize the population(s) of p-ERK immuno-positive neurons seen after MDMA (10 or 30 mg/kg) injection, we subjected drd2-EGFP transgenic mice to the same CPP protocol described above that responded as WT mice (not shown), and then counterstained brain section with a DARPP-32 antibody, a marker of GABAergic medium-size spiny neurons (MSNs). As shown in Figure 5, ERK phosphorylation occurred exclusively in DARPP32-expressing neurons, whereas no staining was detected in D2R (EGFP)-expressing neurons (Figure 5A and 5C). Almost all D1R-expressing neurons displayed ERK activation after MDMA injection (Figure 5B).
###end p 56
###begin title 57
MDMA reexposure after CPP induces strong ERK1/2 activation exclusively in striatonigral medium-sized spiny neurons (MSNs) of the NAcc shell.
###end title 57
###begin p 58
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 140 148 140 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g003">Figure 3</xref>
###xml 235 236 235 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 424 428 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 814 815 803 804 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1109 1110 1094 1095 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1236 1240 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 1315 1316 1300 1301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1441 1445 1426 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 1676 1677 1659 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1732 1733 1715 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1781 1782 1764 1765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1451 1455 <span type="species:ncbi:10090">mice</span>
###xml 1545 1549 <span type="species:ncbi:10090">mice</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
drd2-EGFP BAC transgenic mice, in which EGFP expression is driven by the D2-receptor promoter, were trained for the same CPP protocol as in Figure 3 and re-exposed 24 hours after CPP training to saline, MDMA 10 mg/kg or MDMA 30 mg/kg. A) Single confocal sections showing p-ERK1/2 immunoreactivity (1-3, red) colocalized with D2-mediated EGFP (1'-3', green) and DARPP-32 immunoreactivity (1''-3'', blue) in the NAcc Shell of drd2-EGFP mice 10 minutes after re-exposure to saline (1-1''), MDMA 10 mg/kg (2-2'') or MDMA 30 mg/kg (3-3''). The absolute segregation from D2-EGFP neurons in 1'-3' and the complete colocalization with a fraction of DARPP-32-positive neurons in 1''-3'' reveal the identity of neurons expressing ERK1/2 activation, which are D1 receptor-containing striatonigral MSNs. Scale bar: 40 microm. B) p-ERK1/2 (red) + D2-EGFP (green) + DARPP-32 (blue) colocalized confocal image of the NAcc shell of an animal challenged with 10 mg/kg MDMA. Arrows point to neurons labeled only in blue, which are the small fraction of striatonigral MSNs that do not show ERK activation. Scale bar: 40 microm. C) Quantification of p-ERK1/2 immunoreactive neurons among EGFP-negative (-) or EGFP-positive (+) neurons in the NAcc Shell of drd2-EGFP mice 10 min after saline, MDMA 10 mg/kg or MDMA 30 mg/kg injections. D) Quantification of p-ERK1/2 immunoreactive neurons among EGFP-negative (-) or EGFP-positive (+) neurons in the NAcc Core of drd2-EGFP mice 10 min after saline, MDMA 10 mg/kg or MDMA 30 mg/kg injections. Data (means+/-SEM; n = 3 mice per group) were analyzed using two-way ANOVA with genotype and treatment as main factors, revealing a significant interaction F(2, 12) = 16.8, p<0,001 and a main effect of treatment F(2, 12) = 15.93, p<0,001 as well as of genotype F(1, 12) = 83.71, p<0.001. Bonferroni tests were used for post-hoc comparisons. The null hypothesis was rejected at the p<0.05 level; *** p<0.001 compared to saline-treated mice.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Vezina1">[28]</xref>
###xml 333 335 333 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 486 484 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 656 658 656 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 707 714 707 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g004">Fig. 4A</xref>
###xml 838 840 838 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 891 893 891 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
Sensitization is thought to underlie important aspects of vulnerability to drug addiction [28] and conditioned place preference (CPP) is a robust model used to assess the addictive properties of drugs of abuse. We show here that a "low" dose of MDMA (10 mg/kg) induces locomotor sensitization and CPP only in wildtype but not in 5-HT2B-/- mice. These findings are consistent with: 1) our microdialysis data, showing that either pharmacological inhibition or permanent ablation of 5-HT2B receptors is sufficient to block entirely both 5-HT and DA release in the NAcc following acute MDMA (10 mg/kg) injection [19], 2) lack of accumbal ERK activation in 5-HT2B-/- mice following MDMA (10 mg/kg) conditioning (Fig. 4A). Both behavioral sensitization and CPP following repeated injection of low doses (10 mg/kg) of MDMA are thus entirely 5-HT2B receptor-dependent. These data establish that 5-HT2B receptors are critical for reinforcing effects properties and establishment of long-term alterations of behavioral responses to repeated exposure to MDMA.
###end p 60
###begin p 61
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Girault1">[30]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Valjent2">[32]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Salzmann1">[31]</xref>
###xml 529 531 529 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Cadoni1">[33]</xref>
###xml 1021 1023 1021 1023 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
Several lines of evidence indicate the involvement of the ERK pathway in long-term effects of drugs of abuse [30]. ERK is activated in reward-associated brain areas (including NAcc) through combined stimulation of DA and glutamate receptors after acute or repeated treatment with psychostimulant drugs [32]. Indeed, a previous study showed that MDMA (9 mg/kg)-induced locomotion and CPP were blocked by selective inhibitors of ERK [31]. We show here that a low dose of MDMA (10 mg/kg) induces ERK activation in WT but not in 5-HT2B-/- mice. This is consistent with the absence of CPP in these mice following injection of a low dose of MDMA. Moreover, we find more robust ERK activation in the NAcc shell compared to the core following MDMA injection. This is in line with previous studies showing that ERK activation parallels the DA release seen in the shell compared to the core following MDMA injection [33], supporting a critical involvement of DA release in the shell for the rewarding properties of MDMA. Thus, 5-HT2B receptors are critical for the CPP and ERK phosphorylation observed in mice following repeated injection of a low dose of MDMA.
###end p 61
###begin p 62
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">drd2</italic>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Kawaguchi1">[34]</xref>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 493 494 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Gerfen1">[35]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Gerfen1">[35]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Self1">[36]</xref>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Ramos1">[37]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Benturquia1">[38]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Daniela1">[39]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Acquas1">[40]</xref>
###xml 812 813 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1004 1005 1004 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1133 1134 1133 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1139 1140 1139 1140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1151 1155 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Matamales1">[41]</xref>
###xml 1501 1505 1501 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-BertranGonzalez1">[23]</xref>
###xml 1718 1719 1718 1719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1748 1752 1748 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Zhang1">[42]</xref>
###xml 1754 1758 1754 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Stipanovich1">[43]</xref>
###xml 1940 1944 1940 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Zhang1">[42]</xref>
###xml 1945 1949 1945 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Hope1">[44]</xref>
###xml 2020 2021 2020 2021 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 186 201 <span type="species:ncbi:10090">transgenic mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 1088 1093 <span type="species:ncbi:10090">mouse</span>
In order to characterize the neurons that display increased p-ERK after MDMA injection, we used a DARPP-32 antibody, a marker of GABAergic medium-size spiny neurons (MSNs), in drd2-EGFP transgenic mice subjected to the CPP paradigm. MSNs account for >95% of the striatal neurons in rodents [34]. MSNs projecting to the substantia nigra pars reticulata and medial globus pallidus express mostly DA D1 receptors, whereas MSNs projecting to the lateral globus pallidus express preferentially DA D2 receptors [35]. These two subpopulations are homogenously distributed throughout the striatum, and are known to have opposite effects on behavior [35], [36]. MDMA-induced locomotor activity, behavioral sensitization [37], [38], self-administration [39] and pERK stimulation [40] have all been shown to be reduced in D1 receptor antagonist-treated mice. We show here that ERK phosphorylation, following MDMA injection, occurs exclusively in DARPP32-expressing neurons, whereas no ERK labeling was detected in D2 receptor (EGFP)-expressing neurons. A recent study showed that in this transgenic mouse line, 100% of the MSNs express either D1 or D2 receptors [41]. Thus, our results demonstrate that the ERK activation induced by repeated MDMA injection occurs selectively in D1 receptor-striatonigral MSNs in the NAcc (shell and core). This complete segregation between the striatonigral and striatopallidal circuits within the striatum, in response to MDMA injection, was independently reported for cocaine [23]. Activated ERK, in turn, induces CREB phosphorylation, c-Fos expression, mitogen- and stress-activated kinase-1 (MSK1) activation and histone H3 phosphorylation, all of which further regulate gene expression in D1 receptor-expressing neurons [42], [43]. These gene expression changes may contribute to drug-induced persistent neuroadaptations (i.e., alterations of dendritic morphology, synaptic transmission and synaptic plasticity) [42]-[44]. Our work indicates that MDMA induces DA-dependent ERK activation in D1 receptor-expressing neurons that likely triggers the same signaling cascade as other drugs of abuse.
###end p 62
###begin p 63
###xml 129 131 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Crespi1">[29]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Callaway1">[45]</xref>
###xml 603 605 603 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Doly1">[19]</xref>
###xml 785 791 785 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007952-g002">fig. 2</xref>
###xml 973 975 973 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1106 1108 1106 1108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Federici1">[46]</xref>
###xml 1538 1542 1538 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Baumann1">[47]</xref>
###xml 1642 1646 1642 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Berger1">[48]</xref>
###xml 1975 1979 1975 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Rothman1">[49]</xref>
###xml 1984 1987 1984 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Bankson1">[4]</xref>
###xml 2171 2173 2171 2173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2395 2397 2395 2397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2408 2412 2408 2412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Setola1">[50]</xref>
###xml 2518 2520 2518 2520 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 2149 2154 <span type="species:ncbi:9606">human</span>
###xml 2331 2336 <span type="species:ncbi:9606">human</span>
Our data show that unlike a "low" dose of MDMA (10 mg/kg), a high dose (30 mg/kg) induces locomotor sensitization and CPP in 5-HT2B-/- mice. Since MDMA binds to DAT with a lower affinity than SERT [29] it may, at low (10 mg/kg) or high (30 mg/kg) doses, mostly bind to and reverse SERT or both SERT/DAT, respectively. The contrasting behavior observed between low and high doses in animals provides some evidence that the dose of MDMA affects its mode of action [45]. These findings are consistent with our microdialysis data, showing that either pharmacological inhibition or permanent ablation of 5-HT2B receptors is sufficient to block entirely 5-HT and DA release in the NAcc following a "low" dose of MDMA [19] while a "high" dose of MDMA induces DA release without 5-HT release (fig. 2). These findings support the notion that, according to the dose, MDMA has different pharmacological targets leading to different behavioral effects. A low dose of MDMA induce a 5-HT2B receptor-dependent 5-HT release that most likely promotes subsequent DA release in NAcc, while a "high" dose activates also a 5-HT2B receptor-/5-HT-independent DA release, probably via a direct effect of MDMA on DAT. In this regard, a recent study showed that, according to the dose, MDMA has a dual effect (5-HT dependent or independent) on DA neurons firing [46]. Although some literature supports these observations (i.e., the released 5-HT drives the release of DA), other data showed that fenfluramine, a selective 5-HT releaser, fails to induce DA release [47]. This is probably due to the differential 5-HT releasing capacity of fenfluramine compared to MDMA [48] and the complexity of the regulation of mesolimbic DA activity by 5-HT and its receptors (i.e. differences in the affinities of the various 5-HT receptors for 5-HT, differential effects of 5-HT agonists on second-messenger systems, different receptor desensitization and the nature of the 5-HT receptor expressing neurons) {See [49] and [4] for an extensive discussion}. Alternatively, MDMA and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors at concentrations close to those reported in plasma after a single recreational dose. MDMA and MDA, elicit also a prolonged mitogenic responses in human valvular interstitial cells, via direct activation of 5-HT2B receptors [50]. Thus, the behavioral effect of MDMA may be mediated, in part, through direct action on postsynaptic 5-HT2B receptors.
###end p 63
###begin p 64
###xml 44 46 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 310 312 310 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 312 315 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
That a high dose of MDMA-induced CPP in 5-HT2B-/- mice in a DA-dependent fashion (accumbal ERK activation) suggests that DA release in NAcc is sufficient for the rewarding properties of MDMA whatever mode of DA release (i.e with or without a supportive role of 5-HT). Moreover, the lack of 5-HT release in 5-HT2B-/- or RS127445-treated mice following acute injection of MDMA (30 mg/kg) suggest that MDMA induces CPP and stimulates ERK phosphorylation through an entire 5-HT-independent but DA-dependent mechanism.
###end p 64
###begin p 65
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Parrott1">[51]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Baumann2">[52]</xref>
###xml 343 345 343 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 468 470 468 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Nelson1">[53]</xref>
###xml 859 861 859 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 942 944 942 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1014 1016 1014 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1368 1370 1368 1370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1469 1473 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-BruinsSlot1">[54]</xref>
###xml 1474 1478 1474 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Wainscott1">[56]</xref>
###xml 1621 1623 1621 1623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1655 1658 1655 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Kehne1">[6]</xref>
###xml 1660 1664 1660 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Blessing1">[57]</xref>
###xml 1666 1670 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007952-Shioda1">[58]</xref>
###xml 1696 1698 1696 1698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 38 44 <span type="species:ncbi:9606">humans</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">Human</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
The mean recreational dose of MDMA in humans (oral route) is about 2 mg/kg (70-200 mg of MDMA per pill) [51]. In line with the principle of interspecies drug dose scaling-also still a matter of debate- the low dose of MDMA used in mice is most likely a "high" human dose [52]. This supports the notion that pharmacological blockade of the 5-HT2B receptors in Human might counteract the effect of MDMA after a recreational dose as it did in mice. Unlike SSRIs, the 5-HT2B receptor antagonist RS127445 completely blocks MDMA induced 5-HT and DA release, in response to low dose of MDMA. Moreover, RS127445 has no effect on basal 5-HT extracellular concentration, unlike SSRIs which may induce serotonin syndrome due to a synergistic increase in synaptic serotonin [53]. The fact that reinstatement after CPP extinction is abolished by RS127445, a selective 5-HT2B receptor antagonist in WT mice highlights the putative clinical efficacy of 5-HT2B receptor blockade in the treatment of MDMA abuse. Antagonists of 5-HT2B receptor could serve as promising therapeutic drugs for the prevention of the acute and long-term effects associated with MDMA use, and could be a way to avoid relapse in abstaining MDMA users. In line with this hypothesis, a series of atypical antipsychotics (clozapine, amisulpride, metoclopramine, olanzapine and aripiprazole) that have potent 5-HT2B receptor antagonist properties would be expected to be effective prophylactics against MDMA abuse [54]-[56]. Indeed, some antipsychotics reduces MDMA-stimulated locomotion and hyperthermia, effects believed to be mediated at least in part by the 5-HT2A receptor antagonist properties [6], [57], [58]. The contribution of 5-HT2B receptors to the atypical profile of some benzamide antipsychotic has yet to be investigated, in respect to psychostimulants addictive effects.
###end p 65
###begin p 66
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
We thank Pr. P. Greengard (The Rockefeller 525 University, New York) for kindly providing drd2-EGFP transgenic mice. We deeply appreciate the generous help of Dr Silvina Diaz (Institut du Fer a Moulin, UMR-S0839, Paris, 75005, France) for veterinary assistance and the sharp criticism of statistical analysis.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
Is there a common molecular pathway for addiction?
###end article-title 68
###begin article-title 69
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
###end article-title 69
###begin article-title 70
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.
###end article-title 70
###begin article-title 71
3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
###end article-title 71
###begin article-title 72
Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
###end article-title 72
###begin article-title 73
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
###end article-title 73
###begin article-title 74
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor.
###end article-title 74
###begin article-title 75
###xml 168 172 <span type="species:ncbi:10116">rats</span>
Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
###end article-title 75
###begin article-title 76
The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
###end article-title 76
###begin article-title 77
Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
###end article-title 77
###begin article-title 78
MDMA induced dopamine release in vivo: role of endogenous serotonin.
###end article-title 78
###begin article-title 79
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
###end article-title 79
###begin article-title 80
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.
###end article-title 80
###begin article-title 81
Nuclei and subnuclei gene expression profiling in mammalian brain.
###end article-title 81
###begin article-title 82
Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache?
###end article-title 82
###begin article-title 83
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain.
###end article-title 83
###begin article-title 84
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system.
###end article-title 84
###begin article-title 85
Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
###end article-title 85
###begin article-title 86
Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro.
###end article-title 86
###begin article-title 87
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.
###end article-title 87
###begin article-title 88
Mechanisms of Locomotor Sensitization to Drugs of Abuse in a Two-Injection Protocol.
###end article-title 88
###begin article-title 89
Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade.
###end article-title 89
###begin article-title 90
Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.
###end article-title 90
###begin article-title 91
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.
###end article-title 91
###begin article-title 92
Tolerance and sensitization to the behavioral effects of drugs.
###end article-title 92
###begin article-title 93
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
###end article-title 93
###begin article-title 94
The neural basis of drug craving: an incentive-sensitization theory of addiction.
###end article-title 94
###begin article-title 95
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs.
###end article-title 95
###begin article-title 96
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
###end article-title 96
###begin article-title 97
ERK2: a logical AND gate critical for drug-induced plasticity?
###end article-title 97
###begin article-title 98
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.
###end article-title 98
###begin article-title 99
Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties.
###end article-title 99
###begin article-title 100
Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core.
###end article-title 100
###begin article-title 101
Striatal interneurones: chemical, physiological and morphological characterization.
###end article-title 101
###begin article-title 102
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
###end article-title 102
###begin article-title 103
Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists.
###end article-title 103
###begin article-title 104
###xml 123 127 <span type="species:ncbi:10116">rats</span>
Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.
###end article-title 104
###begin article-title 105
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.
###end article-title 105
###begin article-title 106
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats.
###end article-title 106
###begin article-title 107
###xml 228 231 <span type="species:ncbi:10116">rat</span>
Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core.
###end article-title 107
###begin article-title 108
###xml 116 131 <span type="species:ncbi:10090">transgenic mice</span>
Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice.
###end article-title 108
###begin article-title 109
Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors.
###end article-title 109
###begin article-title 110
A phosphatase cascade by which rewarding stimuli control nucleosomal response.
###end article-title 110
###begin article-title 111
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.
###end article-title 111
###begin article-title 112
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
###end article-title 112
###begin article-title 113
Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
###end article-title 113
###begin article-title 114
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
###end article-title 114
###begin article-title 115
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
###end article-title 115
###begin article-title 116
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
###end article-title 116
###begin article-title 117
###xml 103 108 <span type="species:ncbi:9606">human</span>
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
###end article-title 117
###begin article-title 118
Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
###end article-title 118
###begin article-title 119
###xml 58 62 <span type="species:ncbi:10116">rats</span>
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
###end article-title 119
###begin article-title 120
Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.
###end article-title 120
###begin article-title 121
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.
###end article-title 121
###begin article-title 122
Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
###end article-title 122
###begin article-title 123
###xml 38 43 <span type="species:ncbi:9606">human</span>
Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
###end article-title 123
###begin article-title 124
###xml 146 153 <span type="species:ncbi:9986">rabbits</span>
###xml 158 162 <span type="species:ncbi:10116">rats</span>
Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.
###end article-title 124
###begin article-title 125
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie and grants from the Fondation de France, the Fondation pour la Recherche Medicale, the Fondation pour les Maladies Orphelines, the Association pour la Recherche contre le Cancer, the French Ministry of Research (Agence Nationale pour la Recherche) and the European Community. LM's team is an "Equipe FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 127

